These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2894709)

  • 1. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 2. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
    Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.
    Miyauchi A; Amino N; Tamaki H; Kuma K
    Am J Med; 1988 Sep; 85(3):418-20. PubMed ID: 2901227
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical thyroid dermopathy: clinical and immunological features of two cases.
    Chimini G; Dirienzo W; Schenone F; Cabria M; Ciprandi G
    Boll Ist Sieroter Milan; 1984; 63(6):546-52. PubMed ID: 6152539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of plasma from patients with Graves' disease on foetal mouse hearts in organ culture.
    Nathan AW; Longmore DB; Havard CW; Dandona P
    Br J Exp Pathol; 1983 Oct; 64(5):474-8. PubMed ID: 6139124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of thyroid autoantibodies in the follow up of drug treated Graves' hyperthyroidism.
    Hampel R; Meng W; Meng S; Krabbe S; Ventz M; Männchen E; Kirsch G
    Radiobiol Radiother (Berl); 1987; 28(5):612-4. PubMed ID: 3441609
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ; Bierwolf B; Kuhlmann E; Klugmann T; Dietel P; Fischer S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of thyrotropin-displacing-activity (TDA): evidence of restricted heterogeneity.
    Witte A; Akyol B; Hörterer L; Pickardt CR
    Horm Metab Res; 1986 Dec; 18(12):858-61. PubMed ID: 2880790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the change in serum TBII before and after subtotal thyroidectomy for hyperthyroidism.
    Hoshi T
    Fukushima J Med Sci; 1985 Jun; 31(1):1-16. PubMed ID: 2867960
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid stimulating immunoglobulin in Graves' disease.
    Luttrell BM; Hales IB
    Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological aspects of Basedow's disease].
    Winand R; Etienne-Decerf J; Cornet G; Mahieu P
    Bull Soc Belge Ophtalmol; 1988; 226():9-19. PubMed ID: 2908323
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity.
    Fiorucci MC; Cozzani E; Casu M; Murialdo G; Parodi A; Rebora A
    Acta Derm Venereol; 2005; 85(6):560-1. PubMed ID: 16396820
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical relevance of immunological markers in Graves' disease.
    Mann K; Saller B; Hörmann R
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.